SEC Form 4 · accession 0001209191-17-044475
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan Lynch
Officer — PFO, PAO
Period of report
Jul 6, 2017
Accepted (ET)
Jul 10, 2017 · 7:12 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jul 6, 2017 | A | 6,000 | — | A | 6,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of the Issuer.
- F2These shares of Common Stock are issuable pursuant to a grant of RSUs that vest as follows: (i) 50% on March 31, 2018 and (ii) 50% on March 31, 2019.
- F3Not applicable.